Christopher Jean Chen, MD
Orthopedic Surgery · Berkeley
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 1 carrier
- Office
- 1
- Since medical school
- 30 years
- Washington University School of Medicine, 1996
Offices
1 location
Hospitals listed: 057517 · Alta Bates Summit Medical Center · Alta Bates Summit Medical Center - Alta Bates Camp. That is not proof they admit you there this week.
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Chen’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A75341 · Current
Licensed to practise in California · since 2001 · expires 2028-12-31 · Washington University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Surgery centers they own
- The Surgery Center of Alta Bates Summit Medical CenterAmbulatory Surgery Center · Oakland, CAOwner · accredited by JCInitial Accreditation4 inspections, 4 with deficiencies · last 2017-07-27: Requirements Met
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Alta Bates Summit Medical CenterOakland, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Death rate among surgical inpatients with serious treatable complications: 130.09 (87.72 to 172.46) · 109 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.274, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.227, Oct 2024 – Sep 2025
- Alta Bates Summit Medical Center - Alta Bates CampBerkeley, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.298, Oct 2024 – Sep 2025
See every measure and the patient survey for Alta Bates Summit Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 4 better, 3 the same, 0 worse of 7 measures. Readmissions: 3 better, 6 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 130.09 (87.72 to 172.46) · 109 cases | Better | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.274 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.227 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1 (0.06 to 1.94) · 1,209 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.88 (0.6 to 1.16) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2 · 89 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.9 · 105 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.8 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 447 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.7 · 341 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.2 · 381 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 2,811 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.31) · 7,167 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,659 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.93 (0.92 to 4.94) · 1,668 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.25 (0 to 2.75) · 580 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.67 (1.19 to 4.15) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.17 (0.33 to 12.02) · 633 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 8.11 (4.67 to 11.55) · 619 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.07) · 309 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.39 (0 to 0.96) · 6,085 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.8 · 217 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.724 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.425 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.716 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 12.7 · 416 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.6 · 606 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -30.4 · 359 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -31.8 · 555 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -14.4 · 358 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16 · 382 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.1 (3.2 to 8.2) · 25 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.8 (7.3 to 16) · 25 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.5 · 232 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.9 · 56 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 152 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.8 (11.1 to 20) · 251 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 579 cases | No different | Jan 2024 – Dec 2024 |
What patients said (535 patients answered, 18% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Alta Bates Summit Medical Center - Alta Bates Camp
Behind the star rating — Deaths: 2 better, 5 the same, 0 worse of 7 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 6 the same, 1 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.298 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.18 (0.16 to 2.2) · 730 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.87 (0.51 to 1.23) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 188.12 (132.31 to 243.94) · 50 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 50 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.4 · 189 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.6 · 184 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 103 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 1,585 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.4) · 3,929 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.31 (0.11 to 0.51) · 3,954 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.15 (0.95 to 5.36) · 754 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.62 (0 to 3.33) · 325 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.99 (0.39 to 3.59) · 717 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.85 (2.27 to 19.44) · 326 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.79 (1.08 to 8.49) · 302 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.68 (0.19 to 3.18) · 184 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.17 (0 to 0.88) · 3,240 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.4 · 161 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.207 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.48 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.785 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.4 · 243 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -58.2 · 194 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -12.3 · 177 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 209 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.4 (3.8 to 7.5) · 215 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.2 (9.4 to 15.5) · 215 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.8 · 150 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.2 · 81 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.4 (10 to 18.1) · 315 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1.2) · 137 cases | No different | Jan 2024 – Dec 2024 |
What patients said (449 patients answered, 15% of those asked)
| Cleanliness | 2 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 62% |
| Nurses "always" communicated well | 72% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 53% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 68% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 58% |
| Staff "always" explained new medications | 67% |
| Nurses "always" explained things so they could understand | 67% |
| Nurses "always" listened carefully | 66% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 49% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 38% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$220,338
Medicare paid this office $220,338 for 643 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Replacement of thigh bone and hip joint with prosthesis | 53 | $59,579 | $1,124 |
| Replacement of knee joint, both sides of knee | 32 | $36,761 | $1,114 |
| Return visit (30+ min) | 235 | $33,781 | $107 |
| Short return visit (20+ min) | 330 | $31,013 | $74 |
| New patient visit (45+ min) | 212 | $28,520 | $135 |
See all 12 services
| Replacement of thigh bone and hip joint with prosthesis | 53 | $59,579 | $1,124 |
| Replacement of knee joint, both sides of knee | 32 | $36,761 | $1,114 |
| Return visit (30+ min) | 235 | $33,781 | $107 |
| Short return visit (20+ min) | 330 | $31,013 | $74 |
| New patient visit (45+ min) | 212 | $28,520 | $135 |
| Computer-assisted surgery for muscle and bone procedure | 85 | $10,393 | $121 |
| Aspiration and/or injection of fluid from large joint | 58 | $5,195 | $60 |
| New patient visit (60+ min) | 18 | $3,356 | $186 |
| Imaging guidance for procedure, 60 minutes or less | 55 | $690 | $13 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 16 | $217 | None |
| Injection, dexamethasone sodium phosphate, 1 mg | 32 | $11 | None |
| Injection, lidocaine hcl for intravenous infusion, 10 mg | 31 | $1 | None |
Procedures Medicare counted
| Hip replacement | 101 | More than 97% of doctors who do this |
| Knee replacement | 72 | More than 87% of doctors who do this |
| Lower limb (leg) arthroscopy (minimally invasive joint repair) | 1-10 | None |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Aspiration and/or injection of fluid from large joint | 135 | 90 | 111 | 94 | 73 | 87 |
| Computer-assisted surgery for muscle and bone procedure | 36 | 27 | 31 | 41 | 83 | 86 |
| Replacement of thigh bone and hip joint with prosthesis | 50 | 30 | 51 | 69 | 47 | 53 |
| Replacement of knee joint, both sides of knee | 37 | 27 | 32 | 39 | 43 | 33 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
643 Original Medicare patients in 2024. Average age 77 · Women 69% · Also on Medicaid 7% · Health risk score 0.85. At or below the middle of the specialty; the typical orthopedic surgery clinician is at 1.13.
Conditions among them: High blood pressure 64% · Chronic kidney disease 19% · Cancer 19% · Depression 19% · Coronary heart disease 17% · Diabetes 16% · Atrial fibrillation 13% · Heart failure 7% · COPD 6% · Stroke 6% · Dementia 4%.
The office billed $955,071, Medicare allowed $293,218 and paid $220,338; for 1,723 services of 24 kinds; $5,034 of it was for drugs given in the office and $215,303 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 643 | 1,723 | 77 | 0.85 | $955,071 | $220,338 |
| 2023 | 660 | 1,626 | 77 | 0.86 | $954,126 | $225,115 |
| 2022 | 595 | 1,751 | 76 | 0.87 | $973,358 | $245,911 |
| 2021 | 617 | 2,200 | 76 | 0.93 | $804,543 | $225,459 |
| 2020 | 482 | 1,579 | 75 | 1.04 | $550,945 | $146,393 |
| 2019 | 707 | 1,895 | 75 | 0.97 | $872,198 | $227,932 |
| 2018 | 687 | 1,769 | 75 | 0.99 | $835,204 | $205,042 |
| 2017 | 677 | 2,095 | 74 | 1.05 | $1,025,768 | $244,658 |
| 2016 | 616 | 1,944 | 75 | 1.03 | $820,475 | $202,888 |
| 2015 | 657 | 1,662 | 74 | 1.04 | $785,294 | $202,925 |
| 2014 | 694 | 1,851 | 74 | 0.98 | $898,710 | $234,118 |
| 2013 | 633 | 1,973 | 73 | 1.06 | $892,082 | $235,375 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 12 services
| Replacement of thigh bone and hip joint with prosthesis | 45 | $54,182 | $1,153 |
| Replacement of knee joint, both sides of knee | 42 | $49,519 | $1,152 |
| Short return visit (20+ min) | 402 | $39,071 | $74 |
| New patient visit (45+ min) | 221 | $30,292 | $137 |
| Return visit (30+ min) | 152 | $18,880 | $107 |
| Computer-assisted surgery for muscle and bone procedure | 80 | $10,382 | $125 |
| Aspiration and/or injection of fluid from large joint | 51 | $4,784 | $66 |
| New patient visit (60+ min) | 16 | $3,065 | $192 |
| Imaging guidance for procedure, 60 minutes or less | 46 | $661 | $13 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 27 | $334 | None |
| Injection, dexamethasone sodium phosphate, 1 mg | 21 | $10 | None |
| Injection, lidocaine hcl for intravenous infusion, 10 mg | 39 | $1 | None |
2022: 11 services
| Replacement of thigh bone and hip joint with prosthesis | 67 | $78,606 | $1,139 |
| Replacement of knee joint, both sides of knee | 38 | $44,729 | $1,147 |
| Short return visit (20+ min) | 390 | $44,440 | $76 |
| New patient visit (45+ min) | 215 | $30,028 | $140 |
| Return visit (30+ min) | 121 | $13,450 | $98 |
| Aspiration and/or injection of fluid from large joint | 68 | $5,915 | $63 |
| Computer-assisted surgery for muscle and bone procedure | 40 | $5,158 | $126 |
| New patient visit (60+ min) | 16 | $2,974 | $186 |
| Imaging guidance for procedure, 60 minutes or less | 70 | $987 | $13 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 64 | $899 | None |
| Injection, lidocaine hcl for intravenous infusion, 10 mg | 64 | $2 | None |
2021: 11 services
| Replacement of thigh bone and hip joint with prosthesis | 48 | $59,840 | $1,173 |
| Short return visit (20+ min) | 395 | $43,676 | $80 |
| Replacement of knee joint, both sides of knee | 32 | $37,503 | $1,172 |
| New patient visit (45+ min) | 225 | $32,477 | $144 |
| Return visit (30+ min) | 115 | $13,889 | $116 |
| Aspiration and/or injection of fluid from large joint | 80 | $7,200 | $65 |
| Computer-assisted surgery for muscle and bone procedure | 31 | $3,992 | $129 |
| New patient visit (60+ min) | 12 | $2,314 | $193 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 65 | $921 | None |
| Imaging guidance for procedure, 60 minutes or less | 52 | $762 | $14 |
| Injection, lidocaine hcl for intravenous infusion, 10 mg | 64 | $2 | None |
2020: 10 services
| Replacement of thigh bone and hip joint with prosthesis | 30 | $36,370 | $1,212 |
| Replacement of knee joint, both sides of knee | 27 | $33,244 | $1,231 |
| Short return visit (20+ min) | 328 | $27,262 | $60 |
| New patient visit (45+ min) | 153 | $19,914 | $130 |
| Return visit (30+ min) | 74 | $7,468 | $91 |
| Aspiration and/or injection of fluid from large joint | 71 | $5,129 | $57 |
| Computer-assisted surgery for muscle and bone procedure | 27 | $3,534 | $131 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 64 | $856 | None |
| Imaging guidance for procedure, 60 minutes or less | 30 | $403 | $13 |
| Injection, lidocaine hcl for intravenous infusion, 10 mg | 63 | $2 | None |
2019: 11 services
| Replacement of thigh bone and hip joint with prosthesis | 50 | $60,735 | $1,215 |
| Replacement of knee joint, both sides of knee | 36 | $44,831 | $1,212 |
| Short return visit (20+ min) | 460 | $39,359 | $61 |
| New patient visit (45+ min) | 242 | $32,204 | $133 |
| Return visit (30+ min) | 142 | $14,327 | $90 |
| Aspiration and/or injection of fluid from large joint | 109 | $7,773 | $58 |
| Computer-assisted surgery for muscle and bone procedure | 35 | $4,636 | $129 |
| New patient visit (60+ min) | 17 | $3,067 | $180 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 102 | $1,350 | None |
| Imaging guidance for procedure, 60 minutes or less | 52 | $694 | $13 |
| Injection, lidocaine hcl for intravenous infusion, 10 mg | 101 | $3 | None |
2018: 11 services
| Replacement of thigh bone and hip joint with prosthesis | 51 | $59,879 | $1,152 |
| Replacement of knee joint, both sides of knee | 33 | $38,083 | $1,154 |
| Short return visit (20+ min) | 453 | $37,206 | $55 |
| New patient visit (45+ min) | 260 | $32,607 | $125 |
| Aspiration and/or injection of fluid from large joint | 92 | $7,223 | $57 |
| Return visit (30+ min) | 79 | $6,883 | $84 |
| Computer-assisted surgery for muscle and bone procedure | 31 | $3,798 | $123 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 40 | $1,818 | $45 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 84 | $1,244 | None |
| Imaging guidance for procedure, 60 minutes or less | 53 | $413 | $7 |
| Injection, lidocaine hcl for intravenous infusion, 10 mg | 84 | $2 | None |
2017: 11 services
| Replacement of thigh bone and hip joint with prosthesis | 63 | $73,036 | $1,141 |
| Replacement of knee joint, both sides of knee | 43 | $52,688 | $1,145 |
| Short return visit (20+ min) | 440 | $38,808 | $56 |
| New patient visit (45+ min) | 270 | $34,539 | $128 |
| Aspiration and/or injection of fluid from large joint | 102 | $7,728 | $52 |
| Return visit (30+ min) | 79 | $7,245 | $85 |
| Computer-assisted surgery for muscle and bone procedure | 42 | $5,495 | $122 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 78 | $3,783 | $47 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 93 | $1,202 | None |
| Imaging guidance for procedure, 60 minutes or less | 74 | $550 | $7 |
| Injection, lidocaine hcl for intravenous infusion, 10 mg | 93 | $2 | None |
2016: 11 services
| Replacement of thigh bone and hip joint with prosthesis | 52 | $59,574 | $1,124 |
| Short return visit (20+ min) | 417 | $34,024 | $55 |
| Replacement of knee joint, both sides of knee | 24 | $28,098 | $1,124 |
| New patient visit (45+ min) | 210 | $26,390 | $126 |
| Aspiration and/or injection of fluid from large joint | 119 | $9,968 | $54 |
| Return visit (30+ min) | 77 | $6,923 | $81 |
| New patient visit (30+ min) | 34 | $2,328 | $68 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 43 | $2,005 | $47 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 110 | $1,334 | None |
| Imaging guidance for procedure, 60 minutes or less | 58 | $436 | $7 |
| Injection, lidocaine hcl for intravenous infusion, 10 mg | 109 | $3 | None |
2015: 10 services
| Replacement of thigh bone and hip joint with prosthesis | 35 | $42,237 | $1,173 |
| Replacement of knee joint, both sides of knee | 33 | $42,213 | $1,173 |
| Short return visit (20+ min) | 461 | $41,956 | $58 |
| New patient visit (45+ min) | 140 | $19,110 | $136 |
| New patient visit (30+ min) | 113 | $9,433 | $83 |
| Aspiration and/or injection of fluid from large joint | 107 | $7,462 | $54 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 29 | $1,263 | $44 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 100 | $1,248 | None |
| Imaging guidance for procedure, 60 minutes or less | 49 | $380 | $7 |
| Injection, lidocaine hcl for intravenous infusion, 10 mg | 15 | $0 | None |
2014: 11 services
| Replacement of thigh bone and hip joint with prosthesis | 39 | $45,738 | $1,173 |
| Replacement of knee joint, both sides of knee | 37 | $45,684 | $1,171 |
| Short return visit (20+ min) | 479 | $42,573 | $56 |
| New patient visit (45+ min) | 151 | $20,540 | $136 |
| New patient visit (30+ min) | 127 | $10,401 | $82 |
| Aspiration and/or injection of fluid from large joint | 119 | $8,430 | $55 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 22 | $3,709 | $169 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 65 | $3,026 | $46 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 113 | $1,244 | None |
| Return visit (30+ min) | 11 | $908 | $83 |
| Imaging guidance for procedure, 60 minutes or less | 60 | $439 | $7 |
2013: 12 services
| Replacement of thigh bone and hip joint with prosthesis | 49 | $62,935 | $1,234 |
| Short return visit (20+ min) | 431 | $38,475 | $56 |
| Replacement of knee joint, both sides of knee | 27 | $36,879 | $1,317 |
| New patient visit (45+ min) | 144 | $19,145 | $133 |
| Aspiration and/or injection of fluid from large joint | 117 | $11,562 | $55 |
| New patient visit (30+ min) | 116 | $9,399 | $81 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 17 | $2,876 | $169 |
| Computer-assisted surgery for muscle and bone procedure | 18 | $2,208 | $123 |
| Return visit (30+ min) | 21 | $1,706 | $78 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 35 | $1,440 | $41 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 108 | $1,338 | None |
| Imaging guidance for procedure, 60 minutes or less | 16 | $116 | $7 |
Medicaid work
$0 in 2019
Medicaid paid $0 for 14 billed services this clinician did in 2019, up to 14 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Radiologic examination, knee; complete, 4 or more views | 14 | $0 |
| 2019 | 14 | 1 | 14 | $0 |
| 2018 | 16 | 1 | 16 | $0 |
See the largest Medicaid services in earlier years
2018
| Radiologic examination, knee; complete, 4 or more views | 16 | $0 |
Drugs they prescribed that Part D paid
$9,911
Pharmacies billed $9,911 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 31% of their Part D prescriptions (184 of 596) in 2024. At or below the middle of the specialty; the typical orthopedic surgery clinician is at 31%. Surgeons prescribe little besides pain medicine after an operation, so their opioid share runs high.
568 generic and 28 brand-name prescriptions · $9,911 in drug cost · 116 antibiotic prescriptions to 86 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 23 | $6,169 | $268 |
| Oxycodone-Acetaminophen | 154 | $1,383 | $9 |
| Meloxicam | 218 | $501 | $2 |
| Celecoxib | 21 | $366 | $17 |
| Amoxicillin | 87 | $186 | $2 |
See all 9 drugs
| Eliquis | 23 | $6,169 | $268 |
| Oxycodone-Acetaminophen | 154 | $1,383 | $9 |
| Meloxicam | 218 | $501 | $2 |
| Celecoxib | 21 | $366 | $17 |
| Amoxicillin | 87 | $186 | $2 |
| Ondansetron Odt | 13 | $171 | $13 |
| Cephalexin | 18 | $150 | $8 |
| Hydrocodone-Acetaminophen | 13 | $87 | $7 |
| Tramadol | 17 | $63 | $4 |
Year by year
| 2024 | 596 | 219 | 31% (184) | 5% | $9,911 |
| 2023 | 592 | 221 | 31% (185) | 4% | $11,786 |
| 2022 | 646 | 231 | 34% (218) | 4% | $15,702 |
| 2021 | 534 | 207 | 37% (196) | 5% | $12,127 |
| 2020 | 416 | 164 | 33% (136) | 4% | $9,548 |
| 2019 | 471 | 197 | 41% (195) | 12% | $15,400 |
| 2018 | 511 | 199 | 45% (228) | 20% | $21,310 |
| 2017 | 617 | 216 | 43% (263) | 18% | $21,865 |
| 2016 | 540 | 198 | 37% (197) | 17% | $28,348 |
| 2015 | 452 | 188 | 47% (212) | None | $18,366 |
| 2014 | 518 | 211 | 48% (246) | None | $25,477 |
| 2013 | 466 | 175 | 50% (232) | 10% | $20,942 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 9 drugs
| Eliquis | 18 | $5,448 | $303 |
| Oxycodone-Acetaminophen | 151 | $1,296 | $9 |
| Meloxicam | 197 | $617 | $3 |
| Celecoxib | 19 | $299 | $16 |
| Cephalexin | 23 | $237 | $10 |
| Amoxicillin | 93 | $214 | $2 |
| Azithromycin | 15 | $95 | $6 |
| Hydrocodone-Acetaminophen | 12 | $70 | $6 |
| Tramadol | 17 | $65 | $4 |
2022: 8 drugs
| Eliquis | 17 | $6,368 | $375 |
| Oxycodone-Acetaminophen | 161 | $1,663 | $10 |
| Celecoxib | 106 | $1,402 | $13 |
| Cephalexin | 38 | $495 | $13 |
| Meloxicam | 106 | $373 | $4 |
| Amoxicillin | 96 | $226 | $2 |
| Tramadol | 40 | $116 | $3 |
| Azithromycin | 12 | $110 | $9 |
2021: 8 drugs
| Eliquis | 20 | $6,896 | $345 |
| Oxycodone-Acetaminophen | 152 | $1,764 | $12 |
| Celecoxib | 92 | $1,326 | $14 |
| Meloxicam | 100 | $296 | $3 |
| Cephalexin | 15 | $157 | $10 |
| Amoxicillin | 57 | $134 | $2 |
| Hydrocodone-Acetaminophen | 11 | $118 | $11 |
| Tramadol | 26 | $114 | $4 |
2020: 8 drugs
| Eliquis | 15 | $3,851 | $257 |
| Oxycodone-Acetaminophen | 94 | $1,630 | $17 |
| Celecoxib | 65 | $1,279 | $20 |
| Diclofenac | 15 | $870 | $58 |
| Meloxicam | 93 | $364 | $4 |
| Amoxicillin | 46 | $123 | $3 |
| Naproxen | 12 | $101 | $8 |
| Tramadol | 30 | $98 | $3 |
2019: 7 drugs
| Eliquis | 50 | $8,869 | $177 |
| Oxycodone-Acetaminophen | 129 | $1,567 | $12 |
| Celecoxib | 32 | $1,262 | $39 |
| Meloxicam | 74 | $379 | $5 |
| Amoxicillin | 69 | $177 | $3 |
| Hydrocodone-Acetaminophen | 20 | $174 | $9 |
| Tramadol | 41 | $139 | $3 |
2018: 8 drugs
| Eliquis | 92 | $13,916 | $151 |
| Oxycodone-Acetaminophen | 149 | $2,804 | $19 |
| Celecoxib | 19 | $1,630 | $86 |
| Diclofenac | 12 | $355 | $30 |
| Tramadol | 52 | $240 | $5 |
| Hydrocodone-Acetaminophen | 24 | $184 | $8 |
| Meloxicam | 47 | $182 | $4 |
| Amoxicillin | 69 | $160 | $2 |
2017: 8 drugs
| Eliquis | 99 | $13,590 | $137 |
| Oxycodone-Acetaminophen | 182 | $2,311 | $13 |
| Celecoxib | 27 | $1,952 | $72 |
| Hydrocodone-Acetaminophen | 41 | $382 | $9 |
| Diclofenac | 19 | $322 | $17 |
| Meloxicam | 63 | $172 | $3 |
| Amoxicillin | 69 | $155 | $2 |
| Tramadol | 32 | $152 | $5 |
2016: 9 drugs
| Eliquis | 79 | $9,621 | $122 |
| Celecoxib | 24 | $3,023 | $126 |
| Oxycodone-Acetaminophen | 114 | $2,739 | $24 |
| Hydrocodone-Acetaminophen | 55 | $808 | $15 |
| Meloxicam | 65 | $244 | $4 |
| Diclofenac | 12 | $226 | $19 |
| Amoxicillin | 73 | $184 | $3 |
| Tramadol | 21 | $164 | $8 |
| Levothyroxine | 15 | $136 | $9 |
2015: 8 drugs
| Enoxaparin | 30 | $4,789 | $160 |
| Eliquis | 35 | $4,215 | $120 |
| Celecoxib | 18 | $2,961 | $164 |
| Hydrocodone-Acetaminophen | 134 | $2,017 | $15 |
| Oxycodone-Acetaminophen | 44 | $886 | $20 |
| Amoxicillin | 65 | $172 | $3 |
| Meloxicam | 33 | $150 | $5 |
| Tramadol | 28 | $127 | $5 |
2014: 9 drugs
| Enoxaparin | 69 | $13,525 | $196 |
| Hydrocodone-Acetaminophen | 195 | $2,481 | $13 |
| Voltaren | 14 | $2,060 | $147 |
| Celebrex | 11 | $1,957 | $178 |
| Oxycodone-Acetaminophen | 24 | $471 | $20 |
| Amoxicillin | 71 | $216 | $3 |
| Naproxen | 14 | $154 | $11 |
| Meloxicam | 14 | $82 | $6 |
| Ibuprofen | 12 | $44 | $4 |
2013: 10 drugs
| Enoxaparin | 61 | $14,362 | $235 |
| Hydrocodone-Acetaminophen | 165 | $2,473 | $15 |
| Diclofenac | 21 | $501 | $24 |
| Oxycodone-Acetaminophen | 22 | $212 | $10 |
| Oxycodone | 19 | $200 | $11 |
| Amoxicillin | 62 | $197 | $3 |
| Meloxicam | 23 | $147 | $6 |
| Tramadol | 13 | $104 | $8 |
| Naproxen | 11 | $96 | $9 |
| Ibuprofen | 14 | $55 | $4 |
Money from drug and device companies
$33 in 2025
| 2025 | 1 | 1 | None | $33 |
| 2024 | 2 | 3 | $7,137 | $7,162 |
| 2023 | 2 | 2 | None | $94 |
| 2022 | 2 | 7 | None | $142 |
| 2021 | 1 | 4 | None | $178 |
| 2020 | 1 | 1 | None | $36 |
| 2019 | 3 | 6 | None | $212 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Vertex Pharmaceuticals | Journavx | $33 | 1 payment
|
See the published payment
| Vertex Pharmaceuticals | Meals · 2025-04-29 | Journavx | $33 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $7,162
| Pharmacosmos Therapeutics | Monoferric | $7,137 | 2 payments
|
| Abbvie | Qulipta | $25 | 1 payment
|
2023: $94
| Axogen | Avance Nerve Graft | $62 | 1 payment
|
| Avanos Medical | On-Q* Pump and Accessories | $32 | 1 payment
|
2022: $142
| Shockwave Medical | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $122 | 6 payments
|
| Abbvie | Ubrelvy | $20 | 1 payment
|
2021: $178
| Shockwave Medical | Vascular Lithotripsy | $178 | 4 payments
|
2020: $36
| Stryker | Sage M2 Microclimate Body Pads | $36 | 1 payment
|
2019: $212
| Stryker | Reunion | $160 | 4 payments
|
| Bioventus | Durolane | $27 | 1 payment
|
| Pfizer | Eliquis | $25 | 1 payment
|
Checkups this office reported
6 measures · 2023
Medicare asked this office to report how often certain checkups happened in 2023. This is not a grade for the doctor. A specialist’s patients may not need every screening.
- Medicare’s overall office score
- 77.1 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
| Asked about smokingPatients asked about tobacco, with help to quit if they smoke | 100%That's most of the people this applied to. | 50 |
| Checked for fall riskOlder patients screened for fall risk | 19%That's few of the people this applied to. | 133 |
| Medications listed in the chartVisits where the current medication list was documented | 12%That's few of the people this applied to. | 2,418 |
| Risk-standardized complication rate (RSCR) following elective primary total hip arthroplasty (THA) and/or total knee arthroplasty (TKA) for Merit-based Incentive Payment System (MIPS)As Medicare defines this measure | 0% | None |
| Risky medications in older adultsOlder patients given a medication that is risky at their age | 0%That's few of the people this applied to. Better on this measure. | 140 |
| Weight checked, with a follow-up planPatients whose BMI was recorded and followed up if needed | 38%That's less than half. | 1,335 |
What the office says it does
Boxes the office ticked on its Medicare worksheet for 2023. Nobody checks these.
- COVID-19 Vaccine Achievement for Practice Staff
- Implementation of a Personal Protective Equipment (PPE) Plan
- Invasive Procedure or Surgery Anticoagulation Medication Management
- Patient Navigator Program
- Records advance care plans
Professional record
- NPI
- 1396734505
- Licence
- CA A75341California A75341: Current · expires 2028-12-31
- Trained
- Washington University School of Medicine, 1996 · 30 years ago
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207XS0114X (207XS0114X)
- Mailing address
- 3000 Colby St, Suite 106, Berkeley, CA, 94705
- NPI first listed
- 2005-10-19
- NPI last updated
- 2007-07-08
This is when the NPI record was last certified, not a medical board exam.